. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: Clin Chest Med. 2011 Oct 7;32(4):827–838. doi: 10.1016/j.ccm.2011.08.009

Table 3.

5-year survival and locoregional relapse rate after various therapies for early stage non-small cell lung cancer

Treatment modality	5 year survival	Locoregional relapse rate
Lobectomy	47–90%⁹²	2–28%^26,14
Segmentectomy	57–85%^17,20	8–29%^92,14
Wedge Resection	27–84%^17,20	15–55%^92,22
Conventional Radiotherapy	0–42%⁸¹	60–67%⁷⁹
Stereotactic Body Radiation Therapy	48–71% at 3 years^83,85	22% at 3 years⁸³
Radiofrequency Ablation	48–70% at 2 years⁸⁷	25–64% at 2 years⁸⁷